Algert Global LLC Acquires 11,010 Shares of Chemed Corporation $CHE

Key Points

• Algert Global increased its Chemed stake by 647.6% in the second quarter, purchasing 11,010 additional shares to hold 12,710 shares worth approximately $5.92 million. Institutional investors own 95.85% of the company.
• Chemed reported stronger-than-expected quarterly results, with earnings of $6.06 per share and revenue of $673.25 million, up 8.8% year over year. The company also raised its quarterly dividend from $0.60 to $0.70 per share.
• Analyst sentiment remains cautious: Chemed has an average “Hold” rating and a $530.75 price target, despite some target increases. Shares opened at $520.34 after recently declining 5.1%, while insiders sold 6,537 shares worth $3.41 million over the past three months.

Algert Global LLC boosted its holdings in shares of Chemed Corporation (NYSE:CHE - Free Report) by 647.6% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 12,710 shares of the company's stock after buying an additional 11,010 shares during the period. Algert Global LLC owned approximately 0.10% of Chemed worth $5,920,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in CHE. Sanctuary Advisors LLC bought a new position in Chemed in the 2nd quarter valued at about $490,000. Jericho Financial LLP bought a new position in shares of Chemed in the second quarter valued at approximately $280,000. Connor Clark & Lunn Investment Management Ltd. purchased a new position in shares of Chemed during the second quarter valued at approximately $1,018,000. Bank of Nova Scotia purchased a new position in shares of Chemed during the second quarter valued at approximately $7,592,000. Finally, Compass Financial Management LLC bought a new stake in Chemed during the second quarter worth $52,000. 95.85% of the stock is owned by institutional investors.

Insider Transactions at Chemed

In other Chemed news, EVP Spencer S. Lee sold 1,000 shares of the business's stock in a transaction on Friday, August 21st. The stock was sold at an average price of $541.04, for a total value of $541,040.00. Following the sale, the executive vice president directly owned 13,912 shares in the company, valued at $7,526,948.48. The trade was a 6.71% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Patrick P. Grace sold 190 shares of the business's stock in a transaction on Friday, July 31st. The shares were sold at an average price of $532.00, for a total value of $101,080.00. Following the completion of the sale, the director owned 3,533 shares in the company, valued at approximately $1,879,556. The trade was a 5.10% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 6,537 shares of company stock valued at $3,406,014 in the last three months. 3.33% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

CHE has been the subject of a number of analyst reports. Wall Street Zen raised Chemed from a "hold" rating to a "strong-buy" rating in a research report on Saturday, August 1st. Weiss Ratings raised shares of Chemed from a "hold (c-)" rating to a "hold (c)" rating in a report on Friday, July 17th. Bank of America reiterated a "neutral" rating on shares of Chemed in a research note on Wednesday, July 29th. Royal Bank Of Canada increased their target price on shares of Chemed from $436.00 to $548.00 and gave the company a "sector perform" rating in a report on Thursday, July 30th. Finally, Oppenheimer raised their price target on shares of Chemed from $500.00 to $590.00 and gave the company an "outperform" rating in a research report on Friday, July 31st. One investment analyst has rated the stock with a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat, Chemed currently has an average rating of "Hold" and an average target price of $530.75.

Chemed Trading Down 5.1%

Shares of Chemed stock opened at $520.34 on Friday. The firm has a market cap of $6.80 billion, a PE ratio of 26.13, a P/E/G ratio of 2.08 and a beta of 0.51. Chemed Corporation has a 1 year low of $365.20 and a 1 year high of $557.00. The company has a debt-to-equity ratio of 0.17, a current ratio of 0.91 and a quick ratio of 0.89. The stock has a fifty day moving average price of $507.71 and a 200-day moving average price of $449.15.

Chemed (NYSE:CHE - Get Free Report) last posted its quarterly earnings results on Tuesday, July 28th. The company reported $6.06 earnings per share for the quarter, beating the consensus estimate of $5.60 by $0.46. Chemed had a net margin of 10.60% and a return on equity of 31.77%. The company had revenue of $673.25 million during the quarter, compared to analyst estimates of $665.04 million. During the same quarter in the prior year, the business earned $4.27 earnings per share. The firm's revenue for the quarter was up 8.8% on a year-over-year basis. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. Equities research analysts anticipate that Chemed Corporation will post 23.18 EPS for the current year.

Chemed Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 3rd. Shareholders of record on Monday, August 17th will be issued a dividend of $0.70 per share. This represents a $2.80 annualized dividend and a yield of 0.5%. This is a positive change from Chemed's previous quarterly dividend of $0.60. The ex-dividend date of this dividend is Monday, August 17th. Chemed's dividend payout ratio is currently 14.06%.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corporation (NYSE:CHE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source